Interactions with cells is our passion!

3rd generation biosensors !

Providing high content results -

fast !

Learn how IgG 3-43 blocks tumor cell growth both in vivo and in vitro.

We offer cutting edge technology that provides our customers an advantage when developing new pharmaceuticals.

Our third generation biosensors’ technology is unique and patented.

It reduces animal testing and makes the drug development process more efficient and cost effective.


Swedish press releases including regulatory releases are available in our Swedish news room.

  • Quality control of biological pharmaceuticals

    Attana AB, AstraZeneca, Akzo Nobel Pulp and Performance Chemicals AB and Karlstad University and three more partners have started a new project aiming at developing leading methods for quality […]

  • Attana completes share issue

    Attana has completed its new share issue and will receive SEK 10.5 million before costs. More than SEK 6.1 million was subscribed for by approximately 500 individuals and the guarantee consortium […]

  • New vaccine technology fights cancer in mice

    Attana´s customer at Copenhagen University has in the journal OncoImmunology published a study showing that their vaccine can prevent and fight breast cancer in mice. A new vaccine technology […]

© Attana 2017 | Attana AB